Aura Biosciences (AURA) Total Liabilities (2020 - 2026)

Aura Biosciences' Total Liabilities history runs 7 years deep, the most recent figure standing at $30.4 million for Q1 2026.

• Quarterly Total Liabilities rose 10.92% year-over-year to $30.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $30.4 million (up 10.92% YoY) and the FY2025 annual result came in at $32.5 million, up 6.5% from the prior year.
• Total Liabilities was $30.4 million for Q1 2026 at Aura Biosciences, down from $32.5 million in the prior quarter.
• Across five years, Total Liabilities topped out at $33.4 million in Q3 2025 and bottomed at $5.3 million in Q1 2022.
• A 5-year average of $26.2 million and a median of $28.1 million in 2022 frame the typical range for Total Liabilities.
• Peak annual rise in Total Liabilities reached 382.78% in 2023, while the deepest fall reached 0.16% in 2023.
• Aura Biosciences' Total Liabilities stood at $28.4 million in 2022, then increased by 3.09% to $29.2 million in 2023, then grew by 4.47% to $30.5 million in 2024, then increased by 6.5% to $32.5 million in 2025, then fell by 6.42% to $30.4 million in 2026.
• Business Quant data shows AURA's Total Liabilities at $30.4 million in Q1 2026, $32.5 million in Q4 2025, and $33.4 million in Q3 2025.